Surgical Staging

In general, cancers are divided into categories or stages, with the assignment with a stage based on the risk for recurrence. For vulvar cancer the final stage depends on the pathologic review of the surgical specimens from the vulva and regional lymph nodes.

Stage IA: These lesions do not require a regional lymph node evaluation because of the low risk of metastasis.

Stage 1B: These tumors have deeper invasion (great than 1mm), but the regional lymph nodes are negative. These patients remain in Stage 1 category since they have a no risk for recurrence.

Stage II: The tumors have a local extension to the urethra, anus or vagina with negative lymph nodes. These patients have a lower risk of recurrence than patients described as Stage III.

Stage III: This stage includes patients with lymph node metastases regardless of size, location or extension of the primary vulvar tumor. The presence and extent of lymph node involvement is the single most important factor in the determining the risk of recurrence.

Spotlight

This special section in Self Magazine features a GYN surgeon and 34-year-old (at the time of diagnosis) patient.

Awareness

Check out CervivorTV’s new webisode: 5th National Race to End Women’s Cancer. Hosted by the fabulous cervivor herself, Tamika Felder! Click here.

Research

The Foundation’s research award winners will be notified in January. Thank you to all who sent in their applications.

Education

The Foundation for Women’s Cancer is pleased to announce its upcoming FREE Telephone Education Workshop Dec. 18 on Cervical Cancer. For more information, click here.